Literature DB >> 30242551

Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis.

Rachel Rosovsky1, Yuchiao Chang2, Kenneth Rosenfield3, Richard Channick4, Michael R Jaff5, Ido Weinberg3, Thoralf Sundt6, Alison Witkin4, Josanna Rodriguez-Lopez4, Blair A Parry7, Savannah Harshbarger7, Praveen Hariharan7, Christopher Kabrhel7.   

Abstract

Multidisciplinary pulmonary embolism response teams (PERTs) are being implemented to improve care of patients with life-threatening PE. We sought to determine how the creation of PERT affects treatment and outcomes of patients with serious PE. A pre- and post-intervention study was performed using an interrupted time series design, to compare patients with PE before (2006-2012) and after (2012-2016) implementation of PERT at a university hospital. T-tests, Chi square tests and logistic regression were used to compare outcomes, and multivariable regression were used to adjust for differences in PE severity. Two-sided p-value < 0.05 was considered significant. For the interrupted time-series analysis, data was divided into mutually exclusive 6-month time periods (11 pre- and 7 post-PERT). To examine changes in treatment and outcomes associated with PERT, slopes and change points were compared pre- and post-PERT. Two-hundred and twelve pre-PERT and 228 post-PERT patients were analyzed. Patient demographics were generally similar, though pre-PERT, PE were more likely to be low-risk (37% vs. 19%) while post-PERT, PE were more likely to be submassive (32% vs. 49%). More patients underwent catheter directed therapy (1% vs. 14%, p = < 0.0001) or any advanced therapy (19 [9%] vs. 44 [19%], p = 0.002) post PERT. Interrupted time series analysis demonstrated that this increase was sudden and coincident with implementation of PERT, and most noticeable among patients with submassive PE. There were no differences in major bleeding or mortality pre- and post-PERT. While the use of advanced therapies, particularly catheter-directed therapies, increased after creation of PERT, especially among patients with submassive PE, there was no apparent increase in bleeding.

Entities:  

Keywords:  PERT; Pulmonary embolism; Pulmonary embolism response team; Thrombolysis; Treatment

Mesh:

Year:  2019        PMID: 30242551     DOI: 10.1007/s11239-018-1737-8

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  24 in total

1.  The impact of a pulmonary embolism response team on the efficiency of patient care in the emergency department.

Authors:  Colin Wright; Ayman Elbadawi; Yu Lin Chen; Dhwani Patel; Justin Mazzillo; Nicole Acquisto; Christine Groth; Joseph Van Galen; Joseph Delehanty; Anthony Pietropaoli; David Trawick; R James White; Pamela Cameron; Igor Gosev; Bryan Barrus; Neil G Kumar; Scott J Cameron
Journal:  J Thromb Thrombolysis       Date:  2019-08       Impact factor: 2.300

Review 2.  Thrombolytic therapy in acute venous thromboembolism.

Authors:  Thita Chiasakul; Kenneth A Bauer
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

3.  Effect of a Multidisciplinary Pulmonary Embolism Response Team on Patient Mortality.

Authors:  Colin Wright; Ilan Goldenberg; Susan Schleede; Scott McNitt; Igor Gosev; Ayman Elbadawi; Anthony Pietropaoli; Bryan Barrus; Yu Lin Chen; Justin Mazzillo; Nicole M Acquisto; Joseph Van Galen; Annelise Hamer; Mark Marinescu; Joseph Delehanty; Scott J Cameron
Journal:  Am J Cardiol       Date:  2021-12-15       Impact factor: 2.778

4.  Utilization trends and outcomes of catheter-directed thrombolysis for pulmonary embolism in the US by race/ethnicity.

Authors:  Titilope Olanipekun; Temidayo Abe; Valery Effoe; Abimbola Chris-Olaiya; Isaac Biney; Pramod Guru; Charles Ritchie; Devang Sanghavi
Journal:  J Thromb Thrombolysis       Date:  2022-10-11       Impact factor: 5.221

5.  The Pulmonary Embolism Response Team: Rationale, Operation, and Outcomes.

Authors:  James J Glazier; Skarlet Patiño-Velasquez; Carlos Oviedo
Journal:  Int J Angiol       Date:  2022-08-25

6.  Right ventricular dysfunction is superior and sufficient for risk stratification by a pulmonary embolism response team.

Authors:  Yu Lin Chen; Colin Wright; Anthony P Pietropaoli; Ayman Elbadawi; Joseph Delehanty; Bryan Barrus; Igor Gosev; David Trawick; Dhwani Patel; Scott J Cameron
Journal:  J Thromb Thrombolysis       Date:  2020-01       Impact factor: 2.300

7.  Expert opinion on the creating and operating of the regional Pulmonary Embolism Response Teams (PERT). Polish PERT Initiative.

Authors:  Aleksander Araszkiewicz; Marcin Kurzyna; Grzegorz Kopeć; Marek Roik; Szymon Darocha; Arkadiusz Pietrasik; Mateusz Puślecki; Andrzej Biederman; Roman Przybylski; Jakub Stępniewski; Michał Furdal; Tatiana Mularek-Kubzdela; Piotr Pruszczyk; Adam Torbicki
Journal:  Cardiol J       Date:  2019       Impact factor: 2.737

8.  Changes in Care for Acute Pulmonary Embolism Through A Multidisciplinary Pulmonary Embolism Response Team.

Authors:  Brett J Carroll; Sebastian E Beyer; Tyler Mehegan; Andrew Dicks; Abby Pribish; Andrew Locke; Anuradha Godishala; Kevin Soriano; Jaya Kanduri; Kelsey Sack; Inbar Raber; Cara Wiest; Isabel Balachandran; Mason Marcus; Louis Chu; Margaret M Hayes; Jeff L Weinstein; Kenneth A Bauer; Eric A Secemsky; Duane S Pinto
Journal:  Am J Med       Date:  2020-05-19       Impact factor: 4.965

Review 9.  Contemporary Catheter-Based Treatment Options for Management of Acute Pulmonary Embolism.

Authors:  Maninder Singh; Irfan Shafi; Parth Rali; Joseph Panaro; Vladimir Lakhter; Riyaz Bashir
Journal:  Curr Treat Options Cardiovasc Med       Date:  2021-05-12

10.  American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.

Authors:  Thomas L Ortel; Ignacio Neumann; Walter Ageno; Rebecca Beyth; Nathan P Clark; Adam Cuker; Barbara A Hutten; Michael R Jaff; Veena Manja; Sam Schulman; Caitlin Thurston; Suresh Vedantham; Peter Verhamme; Daniel M Witt; Ivan D Florez; Ariel Izcovich; Robby Nieuwlaat; Stephanie Ross; Holger J Schünemann; Wojtek Wiercioch; Yuan Zhang; Yuqing Zhang
Journal:  Blood Adv       Date:  2020-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.